Preadipocyte factor-1 in maternal, umbilical cord serum and breast milk: The impact of fetal growth.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
02 2019
Historique:
received: 18 08 2018
revised: 07 11 2018
accepted: 12 11 2018
pubmed: 22 11 2018
medline: 27 3 2020
entrez: 22 11 2018
Statut: ppublish

Résumé

To study the concentrations of preadipocyte factor-1 (Pref-1) -an inhibitor of adipocyte differentiation, implicated in adipose tissue metabolism, late metabolic disorders and fetal growth- in maternal and umbilical cord serum, as well as maternal milk and correlate above concentrations with intrauterine growth and other perinatal parameters. Pref-1 concentrations were determined by ELISA in antepartum maternal and umbilical cord serum, as well as day 3 to 4 postpartum breast milk, deriving from 80 women, who delivered 40 appropriate (AGA), 20 large for gestational age (LGA) and 20 intrauterine growth restricted (IUGR) neonates, classified by the use of customized birth-weight standards adjusted for significant determinants of fetal growth. Umbilical cord serum Pref-1 concentrations were significantly higher than antepartum maternal ones (p < 0.001), while breast milk concentrations were the lowest (p < 0.001 concerning umbilical serum, p < 0.001 concerning maternal serum). Umbilical cord serum Pref-1 concentrations were significantly lower in the LGA group than in the AGA one (p = 0.044). Breast milk and maternal serum Pref-1 concentrations did not differ between the three intrauterine growth groups. Maternal serum and breast milk Pref-1 concentrations did not correlate with maternal age, body mass index before and after gestation, birth weight, body length, and customized centile. A positive weak correlation was recorded between maternal serum and milk Pref-1 concentrations (r = 0.238, p = 0.034). Pref-1 concentrations in umbilical cord serum are higher than in antepartum maternal serum, probably pointing to its fetal origin and role in intrauterine growth. Breast milk concentrations, being extremely low, and possibly implying infant protection from metabolic disorders, positively correlate with maternal serum ones, conceivably suggesting a transfer of the substance from the circulation to the breast. Umbilical cord serum Pref-1 concentrations were lower in LGA fetuses/neonates, as compared to respective AGA ones.

Sections du résumé

BACKGROUND/OBJECTIVE
To study the concentrations of preadipocyte factor-1 (Pref-1) -an inhibitor of adipocyte differentiation, implicated in adipose tissue metabolism, late metabolic disorders and fetal growth- in maternal and umbilical cord serum, as well as maternal milk and correlate above concentrations with intrauterine growth and other perinatal parameters.
MATERIAL AND METHODS
Pref-1 concentrations were determined by ELISA in antepartum maternal and umbilical cord serum, as well as day 3 to 4 postpartum breast milk, deriving from 80 women, who delivered 40 appropriate (AGA), 20 large for gestational age (LGA) and 20 intrauterine growth restricted (IUGR) neonates, classified by the use of customized birth-weight standards adjusted for significant determinants of fetal growth.
RESULTS
Umbilical cord serum Pref-1 concentrations were significantly higher than antepartum maternal ones (p < 0.001), while breast milk concentrations were the lowest (p < 0.001 concerning umbilical serum, p < 0.001 concerning maternal serum). Umbilical cord serum Pref-1 concentrations were significantly lower in the LGA group than in the AGA one (p = 0.044). Breast milk and maternal serum Pref-1 concentrations did not differ between the three intrauterine growth groups. Maternal serum and breast milk Pref-1 concentrations did not correlate with maternal age, body mass index before and after gestation, birth weight, body length, and customized centile. A positive weak correlation was recorded between maternal serum and milk Pref-1 concentrations (r = 0.238, p = 0.034).
CONCLUSIONS
Pref-1 concentrations in umbilical cord serum are higher than in antepartum maternal serum, probably pointing to its fetal origin and role in intrauterine growth. Breast milk concentrations, being extremely low, and possibly implying infant protection from metabolic disorders, positively correlate with maternal serum ones, conceivably suggesting a transfer of the substance from the circulation to the breast. Umbilical cord serum Pref-1 concentrations were lower in LGA fetuses/neonates, as compared to respective AGA ones.

Identifiants

pubmed: 30459083
pii: S1043-4666(18)30425-3
doi: 10.1016/j.cyto.2018.11.010
pii:
doi:

Substances chimiques

Calcium-Binding Proteins 0
DLK1 protein, human 0
Membrane Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-148

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Despina D Briana (DD)

National and Kapodistrian University of Athens, Medical School, Athens, Greece.

Aimilia-Eirini Papathanasiou (AE)

National and Kapodistrian University of Athens, Medical School, Athens, Greece.

Stavroula Gavrili (S)

Neonatal Intensive Care Unit, "Alexandra" University and State Maternity Hospital, Athens, Greece.

Sophia Georgantzi (S)

Neonatal Intensive Care Unit, "Alexandra" University and State Maternity Hospital, Athens, Greece.

Antonios Marmarinos (A)

Laboratory of Clinical Biochemistry-Molecular Diagnostics, 2(nd) Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.

Christos Christou (C)

Hellenic Statistical Authority, Athens, Greece.

Konstantinos Voulgaris (K)

Hellenic Statistical Authority, Athens, Greece.

Dimitrios Gourgiotis (D)

Laboratory of Clinical Biochemistry-Molecular Diagnostics, 2(nd) Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.

Ariadne Malamitsi-Puchner (A)

National and Kapodistrian University of Athens, Medical School, Athens, Greece. Electronic address: amalpu@med.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH